This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing

This study has been completed.
Information provided by (Responsible Party):
Montse Palacio, Hospital Clinic of Barcelona Identifier:
First received: November 28, 2008
Last updated: April 4, 2013
Last verified: April 2013
Interventional study to assess the effect of early detection and treatment of bacterial vaginosis in pregnancy on preterm delivery rate.

Condition Intervention
Pregnancy Bacterial Vaginosis Preterm Delivery Other: Screening

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Impact on Prematurity of a First-trimester Screening for Bacterial Vaginosis in Pregnancy Through Weekly Vaginal pH Determination. An Interventional, Community Study.

Resource links provided by NLM:

Further study details as provided by Montse Palacio, Hospital Clinic of Barcelona:

Primary Outcome Measures:
  • Preterm delivery rate [ Time Frame: 12 months ]

Enrollment: 1049
Study Start Date: January 2007
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Weekly screening
Screening and treatment of bacterial vaginosis during pregnancy through self-administered weekly vaginal pH determination.
Other: Screening
Weekly vaginal pH
No Intervention: Observation
Usual care


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Pregnant women

Exclusion Criteria:

  • Diabetes mellitus (pre-gestational)
  • Hypertension (pre-gestational)
  • Malformations on ultrasonography at 12 weeks
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00799500

Hospital Clinic
Barcelona, Catalonia, Spain, 08036
Sponsors and Collaborators
Montse Palacio
  More Information

Responsible Party: Montse Palacio, MD, PhD, Hospital Clinic of Barcelona Identifier: NCT00799500     History of Changes
Other Study ID Numbers: FIS06/0559
Study First Received: November 28, 2008
Last Updated: April 4, 2013

Additional relevant MeSH terms:
Vaginal Diseases
Vaginosis, Bacterial
Premature Birth
Genital Diseases, Female
Bacterial Infections
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications processed this record on September 21, 2017